Jonathan Torrens Olan
Pulmonary Disease · Guaynabo, PRNPI 1831682061
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,720 of the $9,560 with a category attached, or 80.8%. It is spread thinly across 31 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,930, more than ten times the $62 reported in 2020.
Across 223 payments — averaging $42.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Boehringer Ingelheim$1K
- Olympus Corporation Of The Americas$923
- GSK$664
- Intuitive Surgical$548
- Sanofi$502
- plus $4K from 25 others
What the payments were for
- Travel & lodging$1,41215%
- Food & beverage$7,72081%
- Education$4284%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 59 | $1,940 |
| Boehringer Ingelheim | 35 | $1,190 |
| Olympus Corporation Of The Americas | 7 | $923 |
| GSK | 15 | $664 |
| Intuitive Surgical | 5 | $548 |
| Sanofi | 12 | $502 |
| Johnson & Johnson | 16 | $498 |
| United Therapeutics Corporation | 6 | $408 |
| E.r. Squibb & Sons, L.L.C. | 6 | $401 |
| Bayer | 4 | $391 |
| Merck | 13 | $255 |
| Sanofi-aventis U.S. LLC | 4 | $244 |
| Jazz Pharmaceuticals Inc. | 4 | $203 |
| Actelion Pharmaceuticals US, Inc. | 3 | $198 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $189 |
| Caris MPI, Inc. | 1 | $145 |
| PBG Puerto Rico LLC | 5 | $109 |
| Lilly USA, LLC | 1 | $102 |
| Olympus Latin America, Inc. | 3 | $80 |
| Amgen | 3 | $80 |
| Mylan Specialty L.p. | 1 | $76 |
| Genentech, Inc. | 1 | $76 |
| Eli Lilly Export S.A. Puerto Rico Branch | 3 | $73 |
| Pfizer | 2 | $52 |
| AbbVie | 2 | $43 |
| Insmed, Inc. | 1 | $40 |
| Mallinckrodt Hospital Products Inc. | 1 | $38 |
| Mylan LLC | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Harmony Biosciences LLC | 1 | $24 |
| Medicure Pharma Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Spiration Valve System$837
- Da Vinci Surgical System$408
- TEZSPIRE$375
- Adempas$370
- OFEV$369
- ELIQUIS$245
- DUPIXENT$244
- FASENRA$219
- MI CANCER SEEK$145
- TYVASO$140
- XYWAV$133
- AREXVY$125
- TRELEGY ELLIPTA$122
- NUCALA$122
- OPDIVO$119
- AIRSUPRA$119
- ZEPBOUND$102
How this compares
$9,560 in reported general payments places this provider in the 85th percentile of 138 pulmonary disease providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Wixela InhubFluticasone Propion/Salmeterol | 13 | $1,685 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $628 |
| Montelukast Sodium | 35 | $245 |
| Fluticasone Propionate | 16 | $207 |
| Prednisone | 21 | $85 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Guaynabo
- Alvaro Aranda RodriguezGuaynabo$725K
- Elba Martin ReyesGuaynabo$10K
- Maria Betancourt QuilesGuaynabo$6K
- Kimberly Padilla RodriguezGuaynabo$5K
- Jonathan Torres LunaGuaynabo$3K
- Luis Garcia BarretoCoamo$393K
- Luis Nieves GarrasteguiRio Piedras$121K
- Jahaira Serrano DominguezArecibo$102K
- William Villanueva-BosqueArecibo$67K
- Domingo Chardon FelicianoPonce$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.